Skip to main content
TerrAscend logo

TerrAscend — Investor Relations & Filings

Ticker · TSND ISIN · US88105E4052 LEI · 529900Z66HBZ5381EO49 TSX Manufacturing
Filings indexed 608 across all filing types
Latest filing 2026-05-15 Transaction in Own Shar…
Country CA Canada
Listing TSX TSND

About TerrAscend

https://terrascend.com/

TerrAscend is a vertically integrated cannabis operator specializing in cultivation, processing, manufacturing, and retail distribution across key North American markets. The company maintains scaled operations in multiple states, including California, Maryland, New Jersey, Ohio, and Pennsylvania, serving both medical and adult-use consumers. Retail operations are conducted through award-winning dispensary brands such as The Apothecarium and Gage. TerrAscend's product portfolio includes high-quality cannabis flower, concentrates, vaporizables, and whole-plant hemp extracts. The core business strategy emphasizes quality, innovation, and consistency in product development, aiming to meet the evolving needs of its customer base.

Recent filings

Filing Released Lang Actions
News release (section 4.8 of NI 62-104) – English.pdf
Transaction in Own Shares Classification · 93% confidence This document is a corporate news release detailing the renewal and replenishment of TerrAscend’s normal course issuer bid (NCIB), i.e., its share repurchase program. It provides specifics on the authorization to repurchase up to $10 million of common shares, prior purchases, timing, and regulatory context. It is an announcement of the company buying back its own shares, fitting the Transaction in Own Shares category.
2026-05-15 English
News release (section 4.8 of NI 62-104) – English.pdf
Transaction in Own Shares Classification · 85% confidence The document is a press release announcing the Company’s Board approval to commence a normal course issuer bid to repurchase up to $10 million of its own shares over 12 months. This is a share repurchase program, fitting the definition of Transaction in Own Shares (share buyback).
2026-05-15 English
Other.pdf
Regulatory Filings
2026-05-07 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2026-05-07 English
Interim MD&A - English.pdf
Regulatory Filings
2026-05-07 English
Other.pdf
Regulatory Filings
2026-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.